Journal of Controlled Release 2023
8 papers
The 2023 edition of the Journal of Controlled Release featured research focused on targeted drug delivery systems for oncology, neurology, and wound healing. A primary theme involved the development of nanocarriers for tumor immunotherapy, including the use of liposomes for targeted co-delivery and guanidine-modified nanoparticles to activate immune responses. Other oncology-related studies explored prodrug nanoassemblies and redox-responsive delivery systems designed to improve the efficacy and safety of treatments for conditions such as primary central nervous system lymphoma.
Research also addressed localized delivery challenges through biomimetic hybrid nanovesicles for diabetic wounds and hyaluronic acid-modified cationic liposomes for skin penetration. In neurology, studies investigated ROS-responsive micelle systems to support mesenchymal stem cell therapy for ischemic stroke. The year’s publications further included insights into polymeric biomaterials for ophthalmic delivery. Notable contributors to these studies included Rui Wang, Dianlong Jia, Fengjiao Yuan, and Guangyong Li. This body of work reflects an emphasis on stimuli-responsive materials and biomimetic strategies to enhance therapeutic outcomes across diverse clinical applications.
Top Authors
| Author | Papers |
|---|---|
| Junbin Liu | 1 |
| Pan Li | 1 |